Mr. Christopher Hopton reports

SIRONA RETAINS MOMENTUM PUBLIC RELATIONS INC. FOR INVESTOR RELATIONS

Sirona Biochem Corp. has retained Momentum Public Relations Inc. to provide investor relations services to the company.

Momentum Public Relations, a Quebec-based public relations firm, will assist the company in increasing public awareness by managing the company's corporate communications and marketing activities, as well as facilitating dialogue with the company's shareholders, finance professionals, analysts and media contacts.

Max Gagne, president of Momentum Public Relations, commented: "Sirona Biochem is, in my opinion, one of the most promising young biochem companies available on the market. Their proprietary platform of carbohydrate-based molecules has attracted world leaders in the pharma/cosmetic space, such as Valeant Pharmaceuticals. The opportunities with their skin lighteners and anti-aging compounds alone are enormous. We are excited to be joining forces with Sirona and believe the opportunity represents great promise for shareholders."

The agreement with Momentum is for a term of 12 months at $4,500 per month. The company has also agreed to issue to Momentum stock options in the amount of 450,000 shares at an exercise price of 16.5 cents per share. The options will be subject to vesting pursuant to the terms of the company's stock option plan. The agreement is subject to the acceptance of the TSX Venture Exchange.

We seek Safe Harbor.